This approach is unlike mouse modeling experiments, which can only determine the ability of a certain cell type to initiate glioma development in response to overexpression of a gene, such as in the PDGF-driven case, or loss of function of a gene, as in the NF1-driven case, at a particular point in time. This evidence concerns the gene NF1 and glioma.